Rituximab in Multirelapsing Minimal Change Disease (MCD) or Focal Segmental Glomerulosclerosis (FSGS)
Clinical trial NCT00981838 · COMPLETED
Trial details
- NCT number
- NCT00981838
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2011-04-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.